rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2009-10-19
|
pubmed:abstractText |
Treatment of base of tongue (BOT) squamous cell carcinoma (SCC) has traditionally been associated with poor prognosis and significant morbidity. We report a program consisting of concurrent chemoradiation followed by brachytherapy for these patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1097-0347
|
pubmed:author |
|
pubmed:copyrightInfo |
(c) 2009 Wiley Periodicals, Inc. Head Neck, 2009.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1431-8
|
pubmed:meshHeading |
pubmed-meshheading:19405086-Adult,
pubmed-meshheading:19405086-Aged,
pubmed-meshheading:19405086-Aged, 80 and over,
pubmed-meshheading:19405086-Antineoplastic Agents,
pubmed-meshheading:19405086-Brachytherapy,
pubmed-meshheading:19405086-Carboplatin,
pubmed-meshheading:19405086-Carcinoma, Squamous Cell,
pubmed-meshheading:19405086-Chemotherapy, Adjuvant,
pubmed-meshheading:19405086-Cisplatin,
pubmed-meshheading:19405086-Cohort Studies,
pubmed-meshheading:19405086-Disease-Free Survival,
pubmed-meshheading:19405086-Female,
pubmed-meshheading:19405086-Fluorouracil,
pubmed-meshheading:19405086-Humans,
pubmed-meshheading:19405086-Male,
pubmed-meshheading:19405086-Middle Aged,
pubmed-meshheading:19405086-Paclitaxel,
pubmed-meshheading:19405086-Radiation-Sensitizing Agents,
pubmed-meshheading:19405086-Retrospective Studies,
pubmed-meshheading:19405086-Tongue Neoplasms,
pubmed-meshheading:19405086-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Management of squamous cell carcinoma of the base of tongue with chemoradiation and brachytherapy.
|
pubmed:affiliation |
Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA.
|
pubmed:publicationType |
Journal Article
|